Validating RNAseq-Signatures of Vorinostat (VOR) Sensitivity and Resistance in Patients with Newly Diagnosed Glioblastoma (GBM) Treated with VOR, Temozolomide and Radiation Therapy From Alliance N0874/ABTC-0902.
   Google Scholar   
Citation:
J. Clin. Oncol. vol 34 (suppl) abstr 2029
Meeting Instance:
ASCO 2016
Year:
2016
Type:
Abstract
Sub type:
Poster Discussion
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
No
Biospecimen:
Yes
DataSharing:
No
SDC:
Yes
Parents:
None
Children:
2578  
Program:
OGC
Primary Committee:
Neuro-Onc
Sec. Committees:
   
Pharmas:
 
Grants:
U10CA180821, U10CA180882  
Corr. Author:
 
Authors:
                                     
Networks:
ADM403, ALLIANCE, ATLANTIC, CA136, KANSAS, KS055, KS056, KS064, LAPS-MA036, LAPS-MN026, NC002, VCU   
Study
N0874
Multiple Studies, or Legacy Studies in Alliance Study:
ABTC-0902
Phases:
1/2, 1/2
Keywords: